New Drug: intranasal oxytocin

Go down

 New Drug:  intranasal oxytocin Empty New Drug: intranasal oxytocin

Post by Laura on Sat Apr 13, 2013 4:47 am

"The unique science underlying TI-001's robust efficacy and lack of abuse potential is the relationship shared between pain and oxytocin," stated David C. Yeomans, Ph.D., Chief Scientist and Founder of Trigemina and Director of Pain Research at Stanford University School of Medicine. "Prolonged pain increases the amount of oxytocin receptors for the drug to work on. Because of this, those with chronic migraines are in an almost constant state of elevated oxytocin receptor numbers on trigeminal neurons. With nasal delivery, TI-001 directly applies oxytocin to the trigeminal neurons and rapidly produces an analgesic effect, but only in the presence of painful inflammation."

Read more here: http://www.heraldonline.com/2013/04/08/4753219/trigemina-receives-isp-approval.html#storylink=cpy

http://www.heraldonline.com/2013/04/08/4753219/trigemina-receives-isp-approval.html
Laura
Laura

Posts : 206
Join date : 2011-08-04
Age : 54
Location : Baton Rouge, Louisiana, US

https://www.facebook.com/laura.elizabeth.phillips?sk=info

Back to top Go down

 New Drug:  intranasal oxytocin Empty Re: New Drug: intranasal oxytocin

Post by Sarah on Sat Apr 13, 2013 8:02 am

Sounds interesting. Thanks for posting. Smile
Sarah
Sarah
Admin

Posts : 588
Join date : 2011-04-21
Location : Essex, UK

Back to top Go down

Back to top


 
Permissions in this forum:
You cannot reply to topics in this forum